24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Weekly Roundup
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:46
Nagomi Security raises $23 million Series A for proactive defense platform
11:03
Nvidia on verge of completing $700 million acquisition of Run:ai
09:09
Unleashing potential: A collective call to support Israeli startups
08:33
Here’s what’s “truly crucial to the state of Israeli tech”, according to Battery Ventures
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Wiz shareholders finalizing secondary deals worth hundreds of millions of dollars
3
Bill Ackman: "Israel needs support more than ever and I can help"
4
Cyber decacorn Wiz in advanced negotiation to acquire Lacework for $150-200 million
5
Nvidia on verge of completing $700 million acquisition of Run:ai
More news
Weekly Roundup
4 stories about Weekly Roundup
CTech’s Weekly Roundup of Israeli Tech News
13.04.18
|
CTech
In Israeli tech, women are worth half as much as men. Israel set to approve export of cannabis
CTech’s Weekly Roundup of Israeli Tech News
23.03.18
|
CTech
KLA-Tencor buys electronics manufacturing equipment Orbotech for $3.4 billion. Company behind AMD vulnerabilities report denies ties to short selling outfit
CTech’s Weekly Israeli Tech News Roundup
23.02.18
|
CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Latest venture by Mobileye founders valued at $1 billion. Intel leads $50 million investment in public transit app Moovit.
CTech’s Weekly Israeli Tech News Roundup
01.12.17
|
CTech
Amazon’s plans to open local distribution center, Uber’s retreated after facing legal pressure, and Teva is going back to its roots
Please ensure Javascript is enabled for purposes of
website accessibility